Perspective

Split Viewer

Blood Res 2015; 50(2):

Published online June 25, 2015

https://doi.org/10.5045/br.2015.50.2.69

© The Korean Society of Hematology

Reduced-intensity conditioning hematopoietic stem cell transplantation: looking forward to an international consensus

Monazza Chaudhry, M.D.1, and Natasha Ali, M.D.2

1Medical College, The Aga Khan University, Karachi, Pakistan.

2Department of Pathology and Laboratory Medicine/Oncology, The Aga Khan University Hospital, Karachi, Pakistan.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

REFERENCES

  1. Kanate, AS, Pasquini, MC, Hari, PN, Hamadani, M. Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions. World J Stem Cells, 2014;6;69-81.
    Pubmed
  2. Bacigalupo, A, Ballen, K, Rizzo, D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant, 2009;15;1628-1633.
    Pubmed
  3. Reshef, R, Porter, DL. Reduced-intensity conditioned allogeneic SCT in adults with AML. Bone Marrow Transplant, 2015;50;759-769.
    Pubmed
  4. Anasetti, C, Logan, BR, Lee, SJ, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med, 2012;367;1487-1496.
    Pubmed
  5. Barker, JN, Weisdorf, DJ, DeFor, TE, Blazar, BR, Miller, JS, Wagner, JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood, 2003;102;1915-1919.
    Pubmed
  6. Rocha, V, Mohty, M, Gluckman, E, Rio, B, Array. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Curr Opin Oncol, 2009;21;S31-S34.
    Pubmed
  7. McClune, BL, Weisdorf, DJ, Pedersen, TL, et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol, 2010;28;1878-1887.
    Pubmed
  8. Zeng, W, Huang, L, Meng, F, Liu, Z, Zhou, J, Sun, H. Reduced-intensity and myeloablative conditioning allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome: a meta-analysis and systematic review. Int J Clin Exp Med, 2014;7;4357-4368.
    Pubmed
  9. Zhang, L, Zhang, YZ. Reduced-intensity conditioning allogeneic stem cell transplantation in malignant lymphoma: current status. Cancer Biol Med, 2013;10;1-9.
    Pubmed
  10. Martino, R, de Wreede, L, Fiocco, M, et al. Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT. Bone Marrow Transplant, 2013;48;761-770.
    Pubmed

Article

Perspective

Blood Res 2015; 50(2): 69-70

Published online June 25, 2015 https://doi.org/10.5045/br.2015.50.2.69

Copyright © The Korean Society of Hematology.

Reduced-intensity conditioning hematopoietic stem cell transplantation: looking forward to an international consensus

Monazza Chaudhry, M.D.1, and Natasha Ali, M.D.2

1Medical College, The Aga Khan University, Karachi, Pakistan.

2Department of Pathology and Laboratory Medicine/Oncology, The Aga Khan University Hospital, Karachi, Pakistan.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    References

    1. Kanate, AS, Pasquini, MC, Hari, PN, Hamadani, M. Allogeneic hematopoietic cell transplant for acute myeloid leukemia: Current state in 2013 and future directions. World J Stem Cells, 2014;6;69-81.
      Pubmed
    2. Bacigalupo, A, Ballen, K, Rizzo, D, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant, 2009;15;1628-1633.
      Pubmed
    3. Reshef, R, Porter, DL. Reduced-intensity conditioned allogeneic SCT in adults with AML. Bone Marrow Transplant, 2015;50;759-769.
      Pubmed
    4. Anasetti, C, Logan, BR, Lee, SJ, et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med, 2012;367;1487-1496.
      Pubmed
    5. Barker, JN, Weisdorf, DJ, DeFor, TE, Blazar, BR, Miller, JS, Wagner, JE. Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. Blood, 2003;102;1915-1919.
      Pubmed
    6. Rocha, V, Mohty, M, Gluckman, E, Rio, B, Array. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Curr Opin Oncol, 2009;21;S31-S34.
      Pubmed
    7. McClune, BL, Weisdorf, DJ, Pedersen, TL, et al. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome. J Clin Oncol, 2010;28;1878-1887.
      Pubmed
    8. Zeng, W, Huang, L, Meng, F, Liu, Z, Zhou, J, Sun, H. Reduced-intensity and myeloablative conditioning allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome: a meta-analysis and systematic review. Int J Clin Exp Med, 2014;7;4357-4368.
      Pubmed
    9. Zhang, L, Zhang, YZ. Reduced-intensity conditioning allogeneic stem cell transplantation in malignant lymphoma: current status. Cancer Biol Med, 2013;10;1-9.
      Pubmed
    10. Martino, R, de Wreede, L, Fiocco, M, et al. Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with <10% BM blasts: a report from EBMT. Bone Marrow Transplant, 2013;48;761-770.
      Pubmed
    Blood Res
    Volume 59 2024

    Stats or Metrics

    Share this article on

    • line

    Blood Research

    pISSN 2287-979X
    eISSN 2288-0011
    qr-code Download